ISRCTN02245668已完成未知
A non-interventional study on the tolerability of Octagam® 5% and Octagam® 10%
Octapharma AG (Switzerland)0 个研究点目标入组 1,000 人开始时间: 2011年10月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29020871 post-authorisation safety analysis 2018 Results article in https://pubmed.ncbi.nlm.nih.gov/29517417/ (added 14/11/2022)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •All patients treated with Octagam at a participitating site.
排除标准
- •Does not meet inclusion criteria
研究者
相似试验
招募中
不适用
Tolerability and safety of octagam® 5%, octagam® 10% and panzyga®Autoimmune diseasesHaematological DisordersISRCTN68324970Octapharma GmbH (Germany)5,000
进行中（未招募）
1 期
A Study to Assess the Efficacy, Safety and Pharmacokinetics of IONIS SMNRx in Infants With Spinal Muscular AtrophySpinal Muscular Atrophy (SMA)EUCTR2017-000621-12-Outside-EU/EEAIonis Pharmaceuticals, Inc.20
进行中（未招募）
1 期
An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS)Amyotrophic Lateral Sclerosis (ALS)MedDRA version: 20.0Level: PTClassification code 10077024Term: Familial amyotrophic lateral sclerosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 21.1Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2015-004098-33-DKBiogen Idec Research Limited183
进行中（未招募）
1 期
An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS)Amyotrophic Lateral Sclerosis (ALS)MedDRA version: 20.0Level: PTClassification code 10077024Term: Familial amyotrophic lateral sclerosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 21.1Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2015-004098-33-PLBiogen Idec Research Limited183
进行中（未招募）
1 期
An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS)Amyotrophic Lateral Sclerosis (ALS)MedDRA version: 20.0Level: PTClassification code 10077024Term: Familial amyotrophic lateral sclerosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 20.0Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2015-004098-33-SEBiogen Idec Research Limited144